Jazzed About the Options to Buy Jazz

• Posted by Greg Harmon
• on November 6th, 2014

The pharmaceutical space has been redhot. It does not seem to matter what part of that space, when a stock is ready to move it moves big. The next big move may be in Jazz Pharmaceuticals, $JAZZ. This stock had a massive run higher though out 2013 but has been consolidating since them.

The weekly chart above shows that consolidation in an ascending triangle. It reported earnings Wednesday and is now inching back higher. A move and hold over 176 carries a target higher to 229.

At that price it is expensive to add 10 round lots to your portfolio for this ride, but there is no need to. Jazz does not pay a dividend so why not just participate in the upside thorough the options market.

Jazz has options available in June 2015 and then January 2016, and based on the time for the previous move higher, the January chain is preferable. Buying the January 2016 175 Call for $27 to participate may seem expensive. But this cost can be traded away over time. One way is to start with a call calendar, by selling the November 175 Calls to get back $3.50. As these expire look to sell a December Strike. Or if they are in the money buy them back and sell a December strike that nets you a credit. Lather rinse and repeat until January 2016.

Get my book, Trading Options: Using Technical Analysis to Design Winning Options Trades.

---

 

Want to learn more about Dragonfly Capital Views?
Dragonfly Capital Views Performance Through August 2014 Expiry and sign up here

If you like what you see above sign up for deeper analysis and trading strategy by using the Get Premium button above. As always you can see details of individual charts and more on my StockTwits page.

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.

blog comments powered by Disqus